inositol-3,4,5,6-tetrakisphosphate has been researched along with Pancreatic Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Menniti, FS; Nogimori, K; Obie, JF; Oliver, KG; Putney, JW; Shears, SB | 1 |
| Bruzik, KS; Duszyk, M; French, AS; Ho, MW; Shears, SB | 1 |
2 other study(ies) available for inositol-3,4,5,6-tetrakisphosphate and Pancreatic Neoplasms
| Article | Year |
|---|---|
Origins of myo-inositol tetrakisphosphates in agonist-stimulated rat pancreatoma cells. Stimulation by bombesin of myo-inositol 1,3,4,5,6-pentakisphosphate breakdown to myo-inositol 3,4,5,6-tetrakisphosphate.
Topics: Animals; Bombesin; Chromatography, High Pressure Liquid; Inositol; Inositol 1,4,5-Trisphosphate; Inositol Phosphates; Kinetics; Pancreatic Neoplasms; Rats; Tumor Cells, Cultured | 1990 |
Ins(3,4,5,6)P4 specifically inhibits a receptor-mediated Ca2+-dependent Cl- current in CFPAC-1 cells.
Topics: Adenosine Triphosphate; Calcium; Carcinoma, Ductal, Breast; Chloride Channels; Cystic Fibrosis; Electrophysiology; Humans; Inositol Phosphates; Pancreatic Neoplasms; Receptors, Cell Surface; Tumor Cells, Cultured | 1997 |